Teclistamab in Relapsed Refractory Multiple Myeloma Patients on Dialysis: A French Experience

被引：5
|
作者：
Lachenal, Florence [1 ]
Lebreton, Pierre [2 ]
Bouillie, Sylvie [3 ]
Matteo, Gian [4 ]
Aftisse, Hassina [5 ]
Pascal, Laurent [6 ]
Montes, Lydia [7 ]
Macro, Margaret [8 ]
Vignon, Marguerite [9 ]
Harel, Stephanie [10 ]
Fernandez, Mariana [11 ]
Louni, Chanaz [12 ]
Huart, Antoine [13 ]
Perrot, Aurore [14 ]
机构：
[1] GHND Grp Hosp Nord Dauphine, Bourgoin Jallieu, France
[2] Grp Hosp Havre, Le Havre, France
[3] Janssen, Issy Les Moulineaux, France
[4] CH Chambery, Dept Hematol, Chambery, France
[5] Ctr Hosp St Quentin, St Quentin en Yvelines, France
[6] Hop St Vincent De Paul, Lille, France
[7] Ctr Hosp Univ Amiens Picardie, Serv Hematol, Amiens, France
[8] Hop Cote Nacre, Caen, France
[9] Hop Cochin, AP HP, Hematol Clin, Paris, France
[10] St Louis Hosp, Paris, France
[11] Janssen Cilag Spain, Madrid, Spain
[12] IFM, Paris, France
[13] CHU Toulouse Rangueil, Dept Nephrol & Transplantat, Toulouse, France
[14] Univ Toulouse, CHU Toulouse, IUCT O, UPS,Serv Hematol, Toulouse, France
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-180660
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Teclistamab as monotherapy in patients with relapsed or refractory multiple myeloma who received three or more lines of therapy
    Le Grand, Sophie
    Karlin, Lionel
    BULLETIN DU CANCER, 2023, 110 (09) : 871 - 872
  • [22] Real-world schedule de-escalation of teclistamab in patients with relapsed/refractory multiple myeloma
    Tan, Carlyn Rose Co
    Derkach, Andriy
    Maclachlan, Kylee
    Hultcrantz, Malin
    Hassoun, Hani
    Mailankody, Sham
    Shah, Urvi A.
    Rajeeve, Sridevi
    Shah, Gunjan L.
    Scordo, Michael
    Chung, David J.
    Landau, Heather Jolie
    Giralt, Sergio
    Lesokhin, Alexander M.
    Korde, Neha
    Lin, Dee
    Wu, Bingcao
    Fowler, Jessica
    Fernandez, Mariana
    Usmani, Saad Zafar
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [23] Real-World Evaluation of Teclistamab for the Treatment of Relapsed/Refractory Multiple Myeloma (RRMM)
    Asoori, Sireesha
    Popat, Rakesh
    Martinez-Lopez, Joaquin
    Kastritis, Efstathios
    Brunaldi, Larissa
    Bansal, Radhika
    Corraes, Andre De Menezes Silva
    Yong, Kwee
    Mactier, Catriona
    Corona, Magdalena
    Saez Marin, Adolfo Jesus
    Fotiou, Despina
    Dimopoulos, Meletios Athanasios
    Chhabra, Saurabh
    Ailawadhi, Sikander
    Parrondo, Ricardo
    Martin, Thomas
    Durie, Brian G. M.
    Lin, Yi
    BLOOD, 2023, 142
  • [24] Elranatamab vs. teclistamab: battle of the BCMA bispecifics in relapsed/refractory multiple myeloma
    Moore, Donald C.
    Granger, Katelynn
    Hill, Hailey
    Karabinos, Allison
    Davis, James A.
    EXPERT REVIEW OF HEMATOLOGY, 2024, 17 (06) : 197 - 200
  • [25] EXPERIENCE OF A CENTER WITH DVD SCHEME IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
    Lopez Olga, Perez
    Jose Antonio, Marcos Rodriguez
    Velasco Nazaret, Dominguez
    Millan Rafael, Duro
    Fernandez Alicia, Rodriguez
    HAEMATOLOGICA, 2021, 106 (10) : 344 - 344
  • [26] Real-World Safety and Efficacy of Teclistamab for Patients with Heavily Pretreated Relapsed-Refractory Multiple Myeloma
    Dima, Danai
    Davis, James A.
    Ahmed, Nausheen
    Sannareddy, Aishwarya
    Shaikh, Hira
    Mahmoudjafari, Zahra
    Khouri, Jack
    Kaur, Gurbakhash
    Strouse, Christopher
    Valent, Jason
    Larry, Anderson D., Jr.
    Anwer, Faiz
    Abdallah, Al-Ola
    Hashmi, Hamza
    BLOOD, 2023, 142
  • [27] Brazilian Relapsed Refractory Multiple Myeloma Patients Treated with Teclistamab Outside of Clinical Trials as an Expanded Access Program
    Pericole, Fernando
    Lima, Juliana Souza
    Ottoni, Erica
    Ribeiro, Glaciano
    Crusoe, Edvan de Queiroz
    Cunha, Rafael
    Costa, Abel
    Cury, Priscilla
    Maciel, James
    Hungria, Vania T. M.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S196 - S197
  • [28] Teclistamab in relapsed and refractory multiple myeloma: patients characteristics from post marketing acces (acces precoce) in France
    Harel, Stephanie
    de Colella, Jean-Marc Schiano
    Sonntag, Cecile
    Cazaubiel, Titouan
    Garderet, Laurent
    Bouillie, Sylvie
    Javelot, Matthieu
    Vernet, Sophie
    Perrot, Aurore
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S40 - S41
  • [29] Efficacy and safety of teclistamab in relapsed or refractory multiple myeloma: a systematic review and meta-analysis
    Qureshi, Zaheer
    Jamil, Abdur
    Altaf, Faryal
    Siddique, Rimsha
    Ahmed, Faizan
    ANNALS OF HEMATOLOGY, 2024, : 4901 - 4912
  • [30] Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study
    Meera Mohan
    Jorge Monge
    Nishi Shah
    Danny Luan
    Mark Forsberg
    Vineel Bhatlapenumarthi
    Metodi Balev
    Anannya Patwari
    Heloise Cheruvalath
    Divaya Bhutani
    Sharmilan Thanendrarajan
    Binod Dhakal
    Maurizio Zangari
    Samer Al-Hadidi
    Dennis Cooper
    Suzanne Lentzsch
    Frits van Rhee
    Anita D’Souza
    Aniko Szabo
    Carolina Schinke
    Rajshekhar Chakraborty
    Blood Cancer Journal, 14
12345